(Q38582878)

4 September 2017

title

Novel Mediators of Adipose Tissue and Muscle Crosstalk (English)

1 reference

4 September 2017

Henrike Sell

2

0 references

author name string

Ira Indrakusuma

series ordinal

1

1 reference

4 September 2017

Jürgen Eckel

series ordinal

3

1 reference

4 September 2017

publication date

8 September 2015

1 reference

4 September 2017

published in

Current obesity reports

1 reference

4 September 2017

volume

4

1 reference

4 September 2017

issue

4

1 reference

4 September 2017

page(s)

411-417

1 reference

https://scigraph.springernature.com/pub.10.1007/s13679-015-0174-7

4 September 2017

exact match

0 references

cites work

Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Cardioprotective effects of adipokine apelin on myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin, a novel adipokine over-produced in obesity: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin, a newly identified adipokine up-regulated by insulin and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin-13 decreases lipid storage in hypertrophic adipocytes in vitro through the upregulation of AQP7 expression by the PI3K signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin is necessary for the maintenance of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Structural basis for fibroblast growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

FGF21 is an Akt-regulated myokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Muscles, exercise and obesity: skeletal muscle as a secretory organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fibroblast growth factor 21 improves insulin sensitivity and synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Exercise increases serum fibroblast growth factor 21 (FGF21) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Acute exercise induces FGF21 expression in mice and in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Inflammasome is a central player in the induction of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Pro-inflammatory mediation of myoblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Interleukin-1 stimulates catabolism in C2C12 myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Cytokine response of primary human myotubes in an in vitro exercise model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Metabolic control of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Growth factor regulation of autophagy and cell survival in the absence of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Autophagy: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Autophagy as a crosstalk mediator of metabolic organs in regulation of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high-fat diet feeding in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

MicroRNAs and metabolism crosstalk in energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Evidence for the biogenesis of more than 1,000 novel human microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

MicroRNAs in adipose tissue: their role in adipogenesis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

miR-133a regulates adipocyte browning in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Diminished skeletal muscle microRNA expression with aging is associated with attenuated muscle plasticity and inhibition of IGF-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-g expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0174-7

Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice

21 January 2018

1 reference

12 December 2020

A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation

1 reference

12 December 2020

Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine

1 reference

12 December 2020

IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes.

1 reference

12 December 2020

Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet

1 reference

12 December 2020

Stressed Liver and Muscle Call on Adipocytes with FGF21

1 reference

12 December 2020

Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression

1 reference

12 December 2020

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

1 reference

12 December 2020

FFAs and adipokine-mediated regulation of hsa-miR-143 expression in human adipocytes

1 reference

12 December 2020

10.1007/S13679-015-0174-7

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1052664676

0 references

1 reference